1. Home
  2. GNW vs TLX Comparison

GNW vs TLX Comparison

Compare GNW & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNW
  • TLX
  • Stock Information
  • Founded
  • GNW 1871
  • TLX 2015
  • Country
  • GNW United States
  • TLX Australia
  • Employees
  • GNW N/A
  • TLX N/A
  • Industry
  • GNW Life Insurance
  • TLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNW Finance
  • TLX Health Care
  • Exchange
  • GNW Nasdaq
  • TLX Nasdaq
  • Market Cap
  • GNW 3.5B
  • TLX 3.6B
  • IPO Year
  • GNW 2004
  • TLX N/A
  • Fundamental
  • Price
  • GNW $8.55
  • TLX $10.81
  • Analyst Decision
  • GNW Buy
  • TLX Strong Buy
  • Analyst Count
  • GNW 1
  • TLX 4
  • Target Price
  • GNW $10.00
  • TLX $21.00
  • AVG Volume (30 Days)
  • GNW 4.4M
  • TLX 171.5K
  • Earning Date
  • GNW 11-05-2025
  • TLX 01-01-0001
  • Dividend Yield
  • GNW N/A
  • TLX N/A
  • EPS Growth
  • GNW 512.33
  • TLX N/A
  • EPS
  • GNW 0.44
  • TLX 0.04
  • Revenue
  • GNW $7,261,000,000.00
  • TLX $664,225,558.00
  • Revenue This Year
  • GNW N/A
  • TLX N/A
  • Revenue Next Year
  • GNW N/A
  • TLX N/A
  • P/E Ratio
  • GNW $17.63
  • TLX $336.57
  • Revenue Growth
  • GNW N/A
  • TLX 55.35
  • 52 Week Low
  • GNW $5.99
  • TLX $8.93
  • 52 Week High
  • GNW $9.15
  • TLX $30.36
  • Technical
  • Relative Strength Index (RSI)
  • GNW 43.70
  • TLX 56.40
  • Support Level
  • GNW $8.53
  • TLX $9.47
  • Resistance Level
  • GNW $8.89
  • TLX $11.29
  • Average True Range (ATR)
  • GNW 0.19
  • TLX 0.26
  • MACD
  • GNW -0.05
  • TLX 0.15
  • Stochastic Oscillator
  • GNW 15.52
  • TLX 72.02

About GNW Genworth Financial Inc

Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. Majority of the revenue is generated by the Enact segment. The company earns maximum of its revenue in the United States.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: